237 results on '"Ben-Joseph, Rami"'
Search Results
2. Transferability of real-world data across borders for regulatory and health technology assessment decision-making
3. Characteristics of adults newly diagnosed with idiopathic hypersomnia in the United States
4. Use of the SF-36v2 Health Survey as a Screen for Risk of Major Depressive Disorder in a US Population-based Sample and Subgroup With Chronic Pain
5. Increased Risk of Hypertension Onset Among Patients With Narcolepsy Newly Treated With High-Sodium Oxybate (P5-13.002)
6. Transferability of real-world data across borders for regulatory and health technology assessment decision-making
7. Cardiovascular Burden of Narcolepsy Disease (CV-BOND): a real-world evidence study.
8. Efficacy of lurbinectedin in a clinical trial versus other standard of care in a real-world comparator arm in relapsed/refractory small cell lung cancer patients.
9. Cardiovascular Burden of Narcolepsy Disease (CV-BOND): a Real-World Evidence Study (S1.008)
10. The Impact of Overweight and Obesity on the Direct Medical Costs of Truck Drivers
11. The Impact of Obesity on Diabetes, Hyperlipidemia and Hypertension in the United States
12. Economic Costs of Obesity to Self-Insured Employers
13. Estimating the Costs of Opioid Abuse and Dependence from an Employer Perspective: a Retrospective Analysis Using Administrative Claims Data
14. Impact of Body Mass Index on the Incidence of Cardiometabolic Risk Factors in Ambulatory Care Settings over 5 Years or More
15. Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome without Hematopoietic Cell Transplantation in a Real-World Population in the United States: Patient Characteristics, Prior Treatment Patterns, and Time to Diagnosis
16. The Burden of Undiagnosed Opioid Abuse Among Commercially Insured Individuals
17. Predicting Medication Persistence to Buprenorphine Transdermal System
18. Societal Economic Benefits Associated with an Extended-Release Opioid with Abuse-Deterrent Technology in the United States
19. A perspective on the epidemiology of acetaminophen exposure and toxicity in the United States
20. Economic Outcomes Associated with Microvascular Complications of Type 2 Diabetes Mellitus: Results from a US Claims Data Analysis
21. Treatment patterns and characteristics in the second and third-line therapy setting for real-world small cell lung cancer patients.
22. Overall survival throughout treatment course among patients diagnosed with small cell lung cancer.
23. 497 Clinical Presentation Prior to Idiopathic Hypersomnia Diagnosis Among US Adults: A Retrospective, Real-World Claims Analysis
24. 503 Cardio-Vascular Burden of Narcolepsy Disease (CV-BOND): a Real-World Evidence Study
25. 499 Utilization of Diagnostic Sleep Testing Prior to Idiopathic Hypersomnia Diagnosis Among US Adults: A Real-World Claims Analysis
26. Assessment of Cardiometabolic Risk Factors in a National Primary Care Electronic Health Record Database
27. Economic Impact of Potential Drug–Drug Interactions among Osteoarthritis Patients Taking Opioids
28. Economic Impact of Potential CYP450 Pharmacokinetic Drug–Drug Interactions Among Chronic Low Back Pain Patients Taking Opioids
29. Exposure to Potential CYP450 Pharmacokinetic Drug-Drug Interactions among Osteoarthritis Patients: Incremental Risk of Multiple Prescriptions
30. Prevalence of Exposure to Potential CYP450 Pharmacokinetic Drug–Drug Interactions among Patients with Chronic Low Back Pain Taking Opioids
31. Predicting the Prevalence of Cardiometabolic Risk Factors When Clinical Data Are Limited
32. Economic Burden and Risk of Cardiovascular Disease and Diabetes in Patients with Different Cardiometabolic Risk Profiles
33. Age-Specific Impact of Obesity on Prevalence and Costs of Diabetes and Dyslipidemia
34. National economic impact of tirofiban for unstable angina and myocardial infarction without ST elevation; example from the United Kingdom
35. Inhaled Corticosteroids for Asthma Therapy*: Patient Compliance, Devices, and Inhalation Technique
36. Predicting waist circumference from body mass index
37. A meta-analysis of the dose-response relationship of inhaled corticosteroids in adolescents and adults with mild to moderate persistent asthma
38. Resource utilization and charges of patients with and without diagnosed venous thromboembolism during primary hospitalization and after elective inpatient surgery: a retrospective study
39. Opioid Treatment Patterns Following Prescription of Immediate-Release Hydrocodone
40. Characterizing downstream healthcare resource utilization and costs based on prior utilization patterns of immediate-release hydrocodone
41. Characteristics of High-Cost Patients Diagnosed with Opioid Abuse
42. Sources of prescription opioids among diagnosed opioid abusers
43. Impact of middle-of-the-night awakenings on health status, activity impairment, and costs
44. The Economic Burden of Diagnosed Opioid Abuse Among Commercially Insured Individuals
45. Consequences of patient access restrictions to branded oxycodone hydrochloride extended-release tablets on healthcare utilization and costs in US health plans
46. Use of prescription opioids with abuse-deterrent technology to address opioid abuse
47. US practitioner prescribing practices and patient characteristics of those newly treated with a buprenorphine transdermal patch system
48. Medical cost savings associated with an extended-release opioid with abuse-deterrent technology in the US
49. Health-Care Resource Use by Asthmatics in Croatia Health-Care Resource Use by Asthmatics in Croatia
50. Predicting Medication Persistence to Buprenorphine Transdermal System
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.